Division Faculty

Contact Information:
Email:  jsoberman@uthsc.edu
Office:  (901) 448-4166

Clinical/Research Interest:
Cardiovascular pharmacology of arrhythmias and the use of anti-arrhythmic devices.  Additionally, she studies changes in cardiovascular exercise physiology with cardiovascular risk factor modification.  Epidemiologic prospective and retrospective studies are currently investigating gender and race differences in the presentation, diagnosis and prevention of cardiovascular disease.

Residency: Albert Einstein College of Medicine, New York, NY
Fellowship: Montefiore Hospital and Medical Center, New York, NY
Joined UT: 1988

1. Arroyo M, Soberman JE. Adenosine deaminase in the diagnosis of tuberculous pericardial effusion. Am J Med Sci. 2008;335:227-229.
2. Newman KP, Bhattacharya SK, Munir A, Davis RC, Soberman JE, Ramanathan KB. Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans. Vasc Health Risk Manag. 2007;3:743-747.
3. Ribisl PM, Lang W, Jaramillo SA, Jakicic JM, Stewart KJ, Bahnson J, Bright R, Curtis JF, Crow RS, Soberman JE. Exercise capacity and cardiovascular/metabolic characteristics of overweight and obese individuals with type 2 diabetes: the Look AHEAD clinical trial. Diabetes Care. 2007;30:2679-2684.
4. Fitch DA, Soberman JE, de Jongh Curry A. Esophageal Electric Fields are Correlated to Atrial Defibrillation Thresholds: Towards Patient-Specific Optimization of External Atrial Defibrillation. Conf Proc IEEE Eng Med Biol Soc. 2006;1:4378-4381.
5. Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA. Obesity, leptin resistance, and the effects of insulin reduction. Int J Obes Relat Metab Disord. 2004;28:1344-1348.
6. Brown CS, Farmer RG, Soberman JE, Eichner SF. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs. Clin Pharmacokinet. 2004;43:33-56.
7. Self T, Soberman JE, Bubla JM, Chafin CC. Cardioselective beta-blockers in patients with asthma and concomitant heart failure or history of myocardial infarction: when do benefits outweigh risks? J Asthma. 2003;40:839-845.
8. Parker RB, Yates CR, Soberman JE, Laizure SC. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans. Pharmacotherapy. 2003;23:979-987.
9. Soberman J, Chafin CC, Weber KT. Aldosterone antagonists in congestive heart failure. Curr Opin Investig Drugs. 2002;3:1024-1028.
10. Sameri RM, Soberman JE, Finch CK, Self TH. Lower serum digoxin concentrations in heart failure and reassessment of laboratory report forms. Am J Med Sci. 2002;324:10-13.
11. Self TH, Chafin CC, Soberman JE. Effect of disease states on theophylline serum concentrations: are we still vigilant? Am J Med Sci 2000;319:177-182.
12. Demirkan K, Tolley E, Mastin T, Soberman J, Burbeck J, Self T. Salmeterol administration by metered-dose inhaler alone vs metered-dose inhaler plus valved holding chamber. Chest 2000;117:1314-1318.
13. Chafin CC, Soberman JE, Demirkan K, Self T. Beta-blockers after myocardial infarction: do benefits ever outweigh risks in asthma? Cardiology 1999;92:99-105.
14. Hoye WE, Soberman JE, Walters G. Neuropsychological consultation in medical decision making: anosodiaphoria and neglect following embolic infarction associated with bacterial endocarditis. Arch Clin Neuropsychol 1999;14:132-133.